Background-Perivascular adipose tissue (PVAT) surrounds most vessels and shares common features with brown adipose tissue (BAT). Although adaptive thermogenesis in BAT increases energy expenditure and is beneficial for metabolic diseases, little is known about the role of PVAT in vascular diseases such as atherosclerosis. We hypothesize that the thermogenic function of PVAT regulates intravascular temperature and reduces atherosclerosis. Methods and Results-PVAT shares similar structural and proteomics with BAT. We demonstrated that PVAT has thermogenic properties similar to BAT in response to cold stimuli in vivo. Proteomics analysis of the PVAT from mice housed in a cold environment identified differential expression in proteins highly related to cellular metabolic processes. In a mouse model deficient in peroxisome proliferator-activated receptor-␥ in smooth muscle cells (SMPG KO mice), we uncovered a complete absence of PVAT surrounding the vasculature, likely caused by peroxisome proliferator-activated receptor-␥ deletion in the perivascular adipocyte precursor cells as well. Lack of PVAT, which results in loss of its thermogenic activity, impaired vascular homeostasis, which caused temperature loss and endothelial dysfunction. We further showed that cold exposure inhibits atherosclerosis and improves endothelial function in mice with intact PVAT but not in SMPG KO mice as a result of impaired lipid clearance. Proinflammatory cytokine expression in PVAT is not altered on exposure to cold. Finally, prostacyclin released from PVAT contributes to the vascular protection against endothelial dysfunction. Conclusions-PVAT is a vasoactive organ with functional characteristics similar to BAT and is essential for intravascular thermoregulation of cold acclimation. This thermogenic capacity of PVAT plays an important protective role in the pathogenesis of atherosclerosis. The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/
T wo major types of fat tissue exist throughout the body, white adipose tissue (WAT) and brown adipose tissue (BAT). In addition to energy storage, WAT has been recognized as a major endocrine organ that produces hormones and cytokines. 1 Conversely, the main function of BAT is to generate heat, and it is essential for adaptive thermogenesis and energy expenditure. 2, 3 Existence of a functional BAT in adult humans is now accepted and is evidenced by the presence of active BAT in positron emission tomographic scanning, in which high metabolic activity of BAT was shown to be localized to areas close to the clavicular, periaortic, cervical, and suprarenal regions. 4, 5 Growing evidence obtained from human studies indicates that cold-induced activation of BAT increases thermogenesis and energy expenditure. 6 In addition, obese and overweight subjects have lower BAT activity. 7 Thus, BAT has emerged as an attractive target for the treatment of obesity and associated cardiovascular diseases. In fact, fat tissue surrounding the vessels, known as perivascular adipose tissue (PVAT), has long been considered a vessel-supporting connective tissue. 8 Recent studies suggest that PVAT has BAT-like characteristics, 9 which implies that PVAT itself may exert thermogenic activity on cold acclimation, with immediate translation into vascular activity. However, whether cold-induced thermogenesis has a direct effect on vessel biology is not known.
The vasoactive properties of PVAT are under active investigation. Accumulating data indicate that in response to vascular injury, PVAT itself enhances proinflammatory responses within the vasculature, accompanied by a significant downregulation of adiponectin within PVAT. 10, 11 Other studies suggest that PVAT might increase inflammatory responses in the blood vessel wall and promote atherosclerosis. 12 On the other hand, PVAT has anticontractile effects on the vasculature. 13 In the murine vasculature and in human small arteries, the presence of PVAT is associated with a reduced response to vasoconstricting agents, and this effect is reduced in obese subjects with metabolic syndrome. 13 These observations suggest that PVAT could regulate vessel physiology and pathophysiology. Because adipocytes in PVAT have characteristics resembling brown adipocytes, we hypothesize that activation of PVAT during cold acclimation would affect endothelial function and the development of atherosclerosis. In the present study, we have used a wide variety of approaches, including histology, proteomics, and physiological readouts, to evaluate the basic functions of PVAT on the vasculature, as an organ in vivo, and its effects on the development of atherosclerosis. Using a genetic mouse model in which PVAT fails to develop from all vessels, we provide evidence that PVAT has a similar thermoregulatory function as BAT. Furthermore, we show that activation of PVAT during cold acclimation improves endothelial function and protects against atherosclerosis.
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Methods An expanded Methods section is available in the online-only Data Supplement.
Breeding of Mice Lacking PVAT
Mice lacking PVAT were achieved by breeding SM22␣-Cre knock-in mice (SM22␣ CreKI/CreKI ) 14 with peroxisome proliferatoractivated receptor (PPAR)-␥-floxed mice (PPAR-␥ flox/flox ), both on a C57BL/6J background, with a resulting genotype of SM22␣ CreKI/ϩ / PPAR-␥ flox/flox (SMPG KO mice). Littermate control mice (LC) with genotypes of (1) SM22␣ CreKI/ϩ /PPAR-␥ ϩ/ϩ and (2) SM22␣ ϩ/ϩ / PPAR-␥ flox/flox are summarized in online-only Data Supplement Figure I . To study atherosclerosis and endothelial function, SMPG KO mice were crossed with apolipoprotein E knockout mice (ApoE Ϫ/Ϫ ); the resulting offspring, with a genotype of SM22␣ CreKI/ϩ / PPAR-␥ flox/flox /ApoE Ϫ/Ϫ , also lacked PVAT (shown as SMPG KO/ ApoE Ϫ/Ϫ ). LC mice, with genotypes of (1) SM22␣ CreKI/ϩ /PPAR-␥ ϩ/ϩ /ApoE Ϫ/Ϫ and (2) SM22␣ ϩ/ϩ /PPAR-␥ flox/flox /ApoE Ϫ/Ϫ , were selected as controls (shown as LC/ApoE Ϫ/Ϫ ).
Intravascular and BAT Temperature Measurement
Intravascular temperature was monitored in anesthetized mice with a needle thermocouple microprobe (ADInstruments; MLT1406) inserted into the carotid artery by placing the mice on a metal pad prewarmed at a temperature of 35°C. To simultaneously monitor thermal stimuli, a thermometer probe was placed between the mouse back and the pad. BAT temperature was monitored in anesthetized mice with the thermocouple microprobe inserted through a punctured hole generated by a 26-gauge needle in the interscapular area.
Temporal control of BAT temperature was determined by immersing the hindlimbs and tail in either cold (4°C) or warm (50°C) water.
Results

Proteomics Similarities Between PVAT and BAT
PVAT displays BAT-like morphology, with a smaller adipocyte size than WAT ( Figure 1A) , and shares a similar gene expression pattern with BAT in rodents, which includes high expression of BAT marker genes, including uncoupling protein-1 (UCP-1), Cidea, and PPAR-␥ coactivator 1-␣ (PGC-1␣) and coactivator 1-␤ (PGC-1␤; Figure 1B ). 9, 15 To further reinforce the functional similarities between PVAT and BAT, we performed a comparative proteomics analysis of PVAT, BAT, and WAT in ApoE Ϫ/Ϫ mice. Principal component analysis of the proteome profile identified common protein-expression patterns between PVAT and BAT that were distinct from WAT. The matrix profile of the PVAT proteome was similar to that of BAT but clearly distinct from WAT obtained from gonadal, mesenteric, and subcutaneous adipose tissue ( Figure 1C ; online-only Data Supplement Excel File I). In addition, hierarchical cluster analysis demonstrated overlapping protein-expression patterns of PVAT and BAT ( Figure 1D ). These data demonstrate that PVAT has similar structural, genetic, and proteomics features to those of BAT but that are clearly different from those in WAT, which suggests that PVAT might have a similar function to BAT but not WAT.
Loss of PVAT in an SM22␣-Driven PPAR-␥-Deletion Mouse Model
We previously developed a mouse model using an SM22␣-Cre knock-in strategy 14 to delete the adipogenic transcription factor PPAR-␥ in vascular smooth muscle cells (VSMCs; SMPG KO mice). 16 The SM22␣ promoter was transiently activated in perivascular adipocytes during development, as evidenced by X-gal staining of the aortic section obtained from offspring of SM22␣ CreKI/CreKI mice crossed with GtRosa-lacZ reporter mice. Positive ␤-galactosidase activity was readily detected in the aorta and PVAT (Figure 2A ). Thus, failure of PVAT to develop around the vasculature, as shown at the level of the thoracic artery, abdominal artery, and aortic arch ( Figure 2B ), in SMPG KO mice was the result of deletion of PPAR-␥ in perivascular adipocytes during development. PPAR-␥ expression in WAT and BAT remained unaltered in SMPG KO mice ( Figure 2C ). Furthermore, PPAR-␥ deletion was essential to cause the loss of PVAT. For instance, PVAT and BAT tissues from conventional PPAR-␥2 knockout mice (PPAR-␥2 KO) developed normally despite an extremely small mass of epididymal WAT, 17 and PVAT was present in mice with a PPAR-␦ deletion in perivascular adipocytes obtained by crossbreeding SM22␣ CreKI/CreKI mice and PPAR-␦ flox/flox mice 18 (onlineonly Data Supplement Figure II ).
PVAT Has BAT-Like Heat-Generating Properties
We first determined whether BAT produced heat after mice were subjected to environmental changes in temperature.
BAT temperature was monitored in anesthetized mice by placing a thermoprobe directly into the interscapular BAT. Both the hindlimbs and tail were subjected to cold/warm stimuli, and BAT temperature was recorded in a timedependent manner. Exposure of the hindlimbs to cold stimuli (4°C) promoted BAT-dependent heat generation, because the temperature measured in the BAT depot increased along with the duration of cold exposure ( Figure 3A ). Removal of hindlimbs from 4°C conditions and subsequent exposure to warm stimuli (50°C) simultaneously decreased BAT temperature ( Figure 3A ).
Next, we developed optimal experimental conditions in which both thermal stimuli and intravascular temperature could be monitored simultaneously. The intravascular temperature was monitored with a thermometer sensor inserted into the carotid artery in anesthetized mice placed onto a 35°C metal pad to maintain normal body temperature. To simultaneously monitor thermal stimuli, a thermometer probe was placed between the mouse back and the pad ( Figure 3B ). Intravascular temperature was determined in mice in which interscapular BAT had been removed surgically (ϪBAT) compared with sham controls (ϩBAT; online-only Data Supplement Figure III) . Exposure of the mice to a cold stimulus by rapidly reducing the pad temperature to 4°C reduced intravascular temperature in all mice, even though BAT was generating heat ( Figure 3A ) during these experi-mental conditions. However, the intravascular temperature dropped faster in ϪBAT than in ϩBAT mice, which indicates that BAT generates heat to compensate for the reduction in body temperature (Figure 3Ba , 3Bb, and 3C). Next, we investigated the potential heat-producing properties of PVAT using SMPG KO mice. Exposure of SMPG KO mice to a 4°C pad resulted in a further reduction of intravascular temperature compared with LC mice under conditions in which BAT was removed surgically (ϪBAT; Figure 3Bb , 3Bd, and 3C). We defined "response time" as the time difference between the initial fall in pad temperature and the time when intravascular temperature began to drop after the mice were transferred from warm to cold conditions, which indicates blood temperature changes in response to the cold stimuli. As so defined, the response times of SMPG KO mice were shorter than in LC mice regardless of whether BAT was removed surgically ( Figure 3D ), which indicates that PVAT per se has thermogenic properties and generates heat for the maintenance of intravascular temperature.
Thermogenic Activation of PVAT in Response to Long-Term Mild Cold Exposure
In accordance with the thermogenic properties of PVAT during acute cold stimulation, we also demonstrated that PVAT was activated when the animals were housed in a mild cold environment. ApoE Ϫ/Ϫ mice were housed for 2 months at 16°C (mice housed at 22°C served as controls), a suitable temperature for long-term cold exposure in mice. Under these specific temperature conditions, brown fat is also active in humans. 19 Protein-expression patterns in PVAT from mice housed either at 22°C or 16°C were analyzed by hierarchical clustering analysis, which identified 341 known proteins that were increased significantly in PVAT from mice housed at 16°C versus 22°C ( Figure 4A ). Importantly, Gene Ontology analysis classified 54.6% of those as proteins related to cellular metabolic processes, and 48.6% were related to primary metabolic processes (online-only Data Supplement Table I ). Enzymes known to be involved in glycolysis, fatty acid metabolism, the tricarboxylic acid cycle, and the electron transport chain were increased in PVAT from mice housed at 16°C versus 22°C (online-only Data Supplement Figure IV ). In addition, mRNA expression of UCP-1, PGC-1␣, and PGC-1␤ was significantly increased in PVAT from mice housed at 16°C ( Figure 4B ). These changes in the protein and mRNA expression patterns in response to cold conditions strongly indicate that the metabolic activity of cold-housed mice is enhanced, and these metabolic changes in PVAT might translate into biological changes in the contiguous vessels.
Cold-Mediated PVAT Activation Reduces Atherosclerosis
Next, we hypothesized that cold-dependent PVAT activation may directly attenuate the development of atheroscle-rosis. To study this, LC/ApoE Ϫ/Ϫ and SMPG KO/ApoE Ϫ/Ϫ mice were fed a high-fat diet (HFD) and housed either at 16°C or 22°C for 4 months. In LC/ApoE Ϫ/Ϫ mice, total aortic lesion area was significantly lower at 16°C versus 22°C, as shown by en face staining of lipid-rich lesions ( Figure 4C and 4D), which indicates that cold conditions inhibit atherosclerosis. Reduced atherosclerosis at 16°C was associated with a significant reduction of the total cholesterol and triglyceride levels compared with 22°C, whereas high-density lipoprotein remained unaltered (Figure 4E ). In SMPG KO/ApoE Ϫ/Ϫ mice housed at 22°C, atherosclerosis was greater than in LC/ApoE Ϫ/Ϫ mice ( Figure 4C and 4D) , despite the fact that there were no significant changes in total lipid profiles between SMPG KO/ApoE Ϫ/Ϫ and LC/ApoE Ϫ/Ϫ mice at 22°C ( Figure 4E ). These results from SMPG KO/ApoE Ϫ/Ϫ at 22°C are in agreement with the anti-inflammatory role of PPAR-␥ in VSMCs, 20 which confers direct protection against atherosclerosis, rather than a change in lipid metabolism. However, body weights of SMPG KO mice were significantly lower than in LC mice because of the lack of overall PVAT throughout the vasculature, as shown in the aortic tree and the abdominal region ( mice were not reduced at 16°C, as occurred in LC/ ApoE Ϫ/Ϫ mice ( Figure 4E ), despite reduced body weight. Glucose and insulin tolerance tests were not different under any experimental conditions (online-only Data Supplement Figure VI ). This indicates that lack of coldmediated PVAT activation in SMPG KO/ApoE Ϫ/Ϫ mice fails to reduce triglyceride levels, and accordingly, atherosclerosis is not efficiently reduced under cold conditions. To distinguish the contribution of either PVAT or BAT, we next determined whether cold-dependent atheroprotection was still observed after surgical removal of interscapular BAT in ApoE Ϫ/Ϫ (ϪBAT/ApoE Ϫ/Ϫ ) mice. Atherosclerosis (Figure 4F and 4G) and plasma triglyceride levels ( Figure  4H ) in ϪBAT/ApoE Ϫ/Ϫ mice with intact PVAT were still reduced at 16°C versus 22°C, which indicates that the cold environment protected against atherosclerosis even under conditions in which BAT was surgically removed. Taken together, these data indicate that PVAT is centrally involved in the control of vascular homeostasis during atherogenesis.
Cold-Induced PVAT Activation Attenuates Age-Dependent and HFD-Induced Endothelial Dysfunction
We then investigated whether PVAT protects against atherosclerosis via improvement of endothelial function. Acetylcholine (ACh)-induced endothelium-dependent vasodilation is the "gold standard" for evaluation of endothelial function.
In the presence of pathophysiological conditions, ACh constricts the vessels in an endothelium-dependent manner, 21, 22 which has long been recognized as a bona fide indication of endothelial dysfunction. 23 We used this paradoxical vasoconstriction in response to ACh to test endothelial function and determine the vascular responses to PVAT. Carotid artery rings from 8-week-old wild-type mice fed a normal chow diet showed normal vasodilation after ACh administration ( Figure  5A, upper panel) . However, on segments from 28-week-old mice, serial additions of increasing concentrations of ACh caused an initial relaxation and subsequent contraction, evidencing endothelial dysfunction (middle panel). Of interest, Figure 5B ).
Next, we determined whether PVAT activation in response to cold conditions attenuates endothelial dysfunction. In vessels from HFD-challenged 8-week-old LC/ApoE Ϫ/Ϫ mice housed at 16°C, ACh-induced vasoconstriction was significantly reduced compared with mice at 22°C ( Figure 5C , left panel). However, vessels from HFD-challenged age-matched SMPG KO/ApoE Ϫ/Ϫ mice displayed further increased vasoconstriction irrespective of whether mice were housed at 22°C or 16°C ( Figure 5C, right panel) . Thus, cold stimuli improved endothelial function in LC/ApoE Ϫ/Ϫ mice with intact PVAT but not in SMPG KO/ApoE Ϫ/Ϫ mice, which lack PVAT. We further demonstrated that improvement of endothelial function by PVAT was independent of PPAR-␥ in VSMCs. Carotid arteries isolated from 8-week-old SMPG KO or LC mice did not evidence an impaired vasorelaxation in response to ACh ( Figure 5D , left panel), but 28-week-old SMPG KO mice showed increased ACh-induced constriction compared with age-matched LC mice ( Figure 5D , right panel). However, donor PVAT (from 8-week-old C57BL/6J donor mice) still reversed ACh-induced vasoconstriction of either LC or SMPG KO mice ( Figure 5D, right panel) .
In addition, we tested whether the decreased atherosclerosis and improvement of endothelial function observed at 16°C were caused by reduced inflammation on coldinduced PVAT activation. In HFD-fed ApoE Ϫ/Ϫ mice, mRNA expression levels of the proinflammatory cytokines interleukin-6, tumor necrosis factor-␣, and monocyte chemotactic protein-1 were significantly upregulated in the PVAT compared with mice fed with regular chow (onlineonly Data Supplement Figure VII) . However, cytokine expression in the PVAT of HFD-fed ApoE Ϫ/Ϫ mice at 16°C was not different than at 22°C. Thus, cold-dependent inhibition of atherosclerosis was not the result of a reduction in the PVAT inflammatory state per se. Next, we determined whether leukocyte adhesion to endothelial cells was inhibited in the cold condition. The number of rolling leukocytes in the circulation was reduced significantly in LC/ApoE Ϫ/Ϫ mice at 16°C compared with 22°C ( Figure 5E ; online-only Data Supplement Movies), and molecular markers of leukocyte adhesion (eg, VCAM-1) were also reduced ( Figure 5F and 5G) . On the other hand, both the number of rolling leukocytes ( Figure 5E ; onlineonly Data Supplement Movies) and VCAM-1 mRNA expression levels were similar in SMPG KO/ApoE Ϫ/Ϫ mice housed at 22°C and 16°C ( Figure 5G ). In SMPG KO mice, the number of rolling leukocytes and VCAM-1 mRNA was increased compared with those in LC mice ( Figure 5E and 5G ).
Prostacyclin Released by PVAT Improves HFD-Induced Endothelial Dysfunction
Prostacyclin is a potent vasodilator that targets prostacyclin receptors on the vasculature and confers atheroprotection. 24 Evidence of reduced prostacyclin release has been shown in age-related studies and hypertensive conditions. 25 Although the endothelium is a major source of prostacyclin, prostacyclin is also readily detected in PVAT ( Figure 6A ). Consistent with these findings, we showed that (1) prostacyclin released by PVAT declined with age, because levels obtained from the conditioned media of older mice were reduced significantly compared with levels from younger mice; (2) HFD feeding also resulted in a decline in PVAT-derived prostacyclin; and (3) most importantly, prostacyclin released from PVAT was enhanced in mice housed at 16°C compared with 22°C ( Figure 6B ). Therefore, we hypothesized that prostacyclin released by PVAT may contribute to the inhibition of ACh-induced vasoconstriction. Preincubation of vessel rings isolated from HFD-fed ApoE Ϫ/Ϫ mice with the prostacyclin receptor antagonist CAY10441 prevented PVAT from reversing ACh-induced vasoconstriction (Figure 6C ). However, PVAT was still able to reverse AChinduced vasoconstriction after the addition of the prostacyclin synthesis inhibitor U51605 ( Figure 6D ), which indicates that prostacyclin released by PVAT, rather than endothelium-derived prostacyclin, reversed ACh-induced vasoconstriction in our experimental conditions. These data demonstrate that prostacyclin released from PVAT is protective on the endothelium.
Discussion
BAT is essential for adaptive thermogenesis and energy expenditure in human infants. 26 It was previously thought that BAT was converted into WAT after infancy and that a functional BAT did not exist in adults. 2, 3 However, there is accumulating evidence demonstrating that BAT, present in areas close to the clavicular, periaortic, cervical, and suprarenal regions, is activated in response to cold exposure. 4, 5 In addition, recent studies have shown that cold-induced activation of BAT increases energy expenditure 6 and that in obese and overweight subjects, BAT activity is significantly impaired. 7 Collectively, these studies imply that BAT is an attractive target for the treatment of obesity and associated disorders. PVAT is defined as adipose tissue that surrounds vessels. However, PVAT displays BAT-like morphology, which implies that PVAT has BAT-like function. 9, 15 It is important to investigate the function of PVAT in the vasculature to understand and treat cardiovascular diseases. 27 However, the biology, physiology, and pathology of PVAT are unclear. Published data showing a proinflammatory phenotype in PVAT after vascular injury, 28, 29 along with reported secretion of several adipokines/cytokines from PVAT, 15 led to the hypothesis that PVAT may contribute to the development of atherosclerosis. 30, 31 However, there is no experimental evidence to support the idea that PVAT contributes to atherosclerosis. We are the first to report that PVAT, similar to BAT, is a heat-generating organ and is critical for the maintenance of intravascular temperature. Application of an external cold stimulus to mice causes a progressive loss of intravascular temperature. When BAT is surgically removed, the temperature reduction is enhanced, which is consistent with the thermogenic capacity of BAT. Lack of PVAT in SMPG KO mice causes a further loss of intravascular temperature. In mammals, changes in the environmental temperature induce vascular reactions, which involve endothelial and smooth muscle cell functions. This may occur in humans as well, because an increasing intravascular temperature gradient is formed in large veins as blood approaches the heart. 32 Therefore, PVAT is crucial to the regulation of vascular homeostasis.
Atherosclerosis develops generally in association with impaired energy metabolism and endothelial dysfunction. The former is highly related to body temperature. For instance, basal metabolic rates are lower in individuals living in a tropical environment than in residents of a temperate zone. 32 Cold conditions also stimulate glucose uptake 33 and triglyceride clearance. 34 The present study demonstrated that a mild cold environment activates PVAT, as evidenced by increases in enzymes related to metabolic processes when animals were housed at 16°C. As a result of cold-dependent activation of PVAT, the development of atherosclerosis was attenuated. Plasma triglyceride and cholesterol levels were reduced in mice at 16°C. Therefore, the reduced atherosclerotic lesions in mice housed in a cold environment might be a consequence Figure 5 . Perivascular adipose tissue (PVAT) attenuates age-dependent and high-fat diet (HFD)-induced endothelial dysfunction in response to cold conditions. A, Carotid artery rings were preconstricted with 10 Ϫ6 mol/L phenylephrine (PE), and endothelial function of enhancement of total lipid clearance by thermogenic activation of both BAT and PVAT. However, acclimation at 16°C of mice in which BAT was surgically removed still resulted in reduced plasma triglyceride levels and protected against atherosclerosis, which suggests that activation of PVAT alone may be responsible for these effects. In support of this conclusion, we uncovered an overall increased atherosclerotic burden in SMPG KO/ApoE Ϫ/Ϫ mice housed at room temperature, which was not reduced in cold conditions.
This SMPG KO mouse model lacking PVAT was genetically achieved by breeding SM22␣-Cre knock-in mice (SM22␣ CreKI/ CreKI) 14 with PPAR-␥ flox/flox mice, 16 and those animals were subsequently bred with ApoE Ϫ/Ϫ mice to obtain SMPG KO/ ApoE Ϫ/Ϫ mice with a genotype of SM22␣ CreKI/ϩ /PPAR-␥ flox/flox / ApoE Ϫ/Ϫ . These animals lack PVAT for the following reasons. First, although SM22␣ is one of the earliest markers of differentiated smooth muscle cells, it is also expressed in mesenchymal populations surrounding the aorta as early as embryonic day 9.0. 35 The present data showed that SM22␣ was transiently expressed in perivascular adipocyte precursor cells as well. This is consistent with reports showing that perivascular precursor cells might share the same developmental origin as VSMCs. 36 -38 Therefore, when SM22␣ CreKI/CreKI mice are crossed with PPAR-␥ flox/flox mice, PPAR-␥ is deleted in both VSMCs and perivascular precursor cells. As a consequence, no adipose tissue is visible around the major arteries in our model. Second, PPAR-␥ but not PPAR␦ is a key regulator of white and brown adipocyte differentiation, and even when tissuespecific PPAR␦ knockout is generated with the same SM22␣-Cre knock-in strategy, 18 PVAT is present in those animals. In this regard, it was reported that SM22␣ deficiency increased atherosclerosis in mice, 39 and our SM22␣-Cre knock-in strategy to obtain SMPG KO mice led to SM22␣ knockdown as well. However, as we and others have reported previously, heterozygous SM22␣ CreKI/ϩ mice, in which 1 allele is left intact to allow endogenous SM22␣ expression, did not show any VSMC-related phenotype, including atherosclerosis or blood pressure regulation. 16, 39, 40 Therefore, the use of heterozygous SM22␣ Cre/ϩ mice in the present study excludes the potential contribution of SM22␣ deficiency on atherosclerosis.
Concurrent PPAR-␥ deletion in VSMCs, heart, and skeletal muscle, as in our SMPG KO/ApoE Ϫ/Ϫ mice, although necessary to achieve a phenotype of total absence of PVAT surrounding the vasculature, constitutes a shortcoming of the present study. In addition, HFD-fed SMPG KO/ApoE Ϫ/Ϫ mice are leaner because of the lack of PVAT throughout the vasculature, including the aortic arch, thoracic and abdominal aorta, and a significant reduction of mesenteric fat. However, PPAR-␥ deletion in VSMCs, heart, and skeletal muscle and body weight reduction did not result in impaired energy balance, because the plasma lipid profile in SMPG KO/ ApoE Ϫ/Ϫ mice was not different from that in LC/ApoE Ϫ/Ϫ mice at room temperature. Indeed, prior work, 20 including ours, 16 has demonstrated that PPAR-␥ deletion in VSMCs does not affect plasma lipid profiles and whole-body metabolism. PPAR-␥ deletion in VSMCs contributed significantly to atherosclerosis, 20 as we confirmed in SMPG KO/ApoE Ϫ/Ϫ mice at 22°C. Chronic deficiency of PPAR-␥ in VSMCs cannot be excluded as a contributor to atherosclerosis in SMPG KO/ApoE Ϫ/Ϫ mice. We also cannot exclude the possibility that the ensuing PPAR-␥ deletion in the heart and skeletal muscle might contribute to atherosclerosis in these studies, because heart and skeletal muscle are major organs that account for a large extent of energy expenditure. However, the present data showing that total plasma cholesterol and triglyceride levels were not reduced in SMPG KO/ ApoE Ϫ/Ϫ mice housed at 16°C but were reduced in LC/ ApoE Ϫ/Ϫ mice argue for a prevalent role of thermogenic activation of PVAT rather than PPAR-␥ deletion in VSMCs, heart, and skeletal muscle. In SMPG KO mice, colddependent PVAT activation did not occur, and thus, failure to clear plasma lipids contributed to atherosclerosis in the 16°C environment. In addition, PVAT thermogenic activation reduced atherosclerosis even under conditions in which BAT was surgically removed. Furthermore, donor PVAT efficiently reversed endothelial dysfunction of vessels isolated from SMPG KO mice. As a whole, these data demonstrate a significant contribution of the thermogenic activation of PVAT to inhibition of atherosclerosis, resulting in improvement of endothelial function in a cold environment.
The present study further demonstrated that prostacyclin derived from PVAT declines with age and HFD feeding and increases in mice during cold acclimation, which suggests that activation of PVAT leads to secretion of vasoactive agents and that prostacyclin is one of the major factors contributing to vasculoprotection against HFDinduced endothelial dysfunction in these conditions. It was reported that PVAT releases other specific factors, called PVAT-derived relaxing factors (PVATRFs), that attenuate agonist-induced (eg, phenylephrine, serotonin, angiotensin II, and U46619) vasoconstriction. 41 Such PVAT-derived relaxing factors relax the vasculature through direct effects on the VSMC layers. 42 However, at this time, we have no evidence to address whether prostacyclin derived from PVAT directly relaxes VSMC layers in vivo. It is not likely that prostacyclin from PVAT exerts effects directly on VSMCs to relax vessels in our in vitro experimental conditions. ACh-induced vasoconstriction, an indication of endothelial dysfunction, is endothelium dependent. 43 Additionally, after removal of the endothelium, prostacyclin released by PVAT did not further dilate vessels (data not shown), thus arguing that the effects observed were circumscribed to endothelial cells.
In summary, the present study demonstrates for the first time that PVAT, while sharing similar structural characteristics and proteomics profile to BAT, plays a key role in intravascular thermoregulation. Cold-induced PVAT activation prevents temperature loss in the vasculature and controls vascular tone under disease conditions. Of significance, we show that lack of PVAT, which results in impaired thermogenic capacity, increases atherosclerosis, which reinforces a direct beneficial impact of PVAT adaptive thermogenesis in protection against cardiovascular diseases. The production of prostacyclin was monitored by measurement of 6-keto-PGF1␣ from PVAT, brown adipose tissue (BAT), and white adipose tissue (WAT) in either minced tissue or collected from the conditioned media obtained from intact tissue isolated from C57BL/6J mice. Urine served as a positive control. Data are shown as box plots. nϭ5. B, Prostacyclin release was measured in PVAT of 8-week-old apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice on a regular chow diet (CD) or HFD and housed at 22°C or 16°C for 2 months. Data are shown as box plots (whiskers: minimum to maximum). nϭ7. C, Pretreatment of carotid artery rings isolated from HFD-fed mice with CAY10441 (10 Ϫ7 mol/L), a prostacyclin receptor antagonist, prevents PVAT-dependent inhibition of acetylcholineinduced vasoconstriction. D, Pretreatment of carotid artery rings isolated from HFD-fed mice with U51605 (10 Ϫ7 mol/L), a prostacyclin synthase inhibitor, failed to block PVAT-dependent inhibition of acetylcholine-induced vessel constriction. **PϽ0.01 after vs before PVAT incubation. Quantitative data shown are meanϮSE; nϭ10.
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